GlaxoSmithKline Pharmaceuticals

Indian pharmaceutical company

GlaxoSmithKline Pharmaceuticals Ltd

Company type| Public

Traded as

| BSE: 500660
NSE: GLAXO
Industry| Pharmaceuticals & healthcare
Predecessor| Laboratories (I) Ltd
Founded| 13 November 1924 (1924-11-13) as H. J. Foster & Co. Limited[1]
Headquarters|

Mumbai, Maharashtra

India

Products| Medicines and vaccines
Revenue|  ₹3,723 crore (US$440 million) (2025)

Operating income

|  ₹1,169 crore (US$140 million) (2025)

Net income

|  ₹915 crore (US$110 million) (2025)

Number of employees

| 3,100 (2025)[2]
Parent| GSK
Website| india-pharma.gsk.com
Footnotes / references
Financials as of 31 March 2025[update].[3]

GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK.[4][5] The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others.[6]

## History

[edit]

It was founded 13 November 1924 in India under the name of H.J.Foster & Co. Limited as an Agency House for distributing Baby Food Glaxo, Joseph Nathan & Co. In 1950, it changed its name to Laboratories (I) Ltd.[1]

Old GlaxoSmithKline logo until 9 June 2022

## References

[edit]

1. ^ a b "GlaxoSmithKline Pharmaceuticals Ltd". The Economic Times. Retrieved 3 May 2020.
2. ^ "GlaxoSmithKline Pharmaceuticals Limited - Company". Gsk-india.com. 30 June 2010. Retrieved 30 September 2010.
3. ^ "Annual Report FY2024-25" (PDF). GlaxoSmithKline Pharmaceuticals Limited. Retrieved 11 July 2025.
4. ^ "GlaxoSmithKline Pharmaceuticals Limited, Business Wire India, Press Releases, Dr. A Ramachandran". Businesswireindia.com. Archived from the original on 27 October 2010. Retrieved 30 September 2010.
5. ^ "GSK Pharma plans more investments to support growth". The Hindu Business Line. 28 April 2010. Retrieved 30 September 2010.
6. ^ "GlaxoSmithKline: Glaxo baby grows up". Business Today. Retrieved 29 January 2022.

* v
* t
* e

GSK

Subsidiaries|

| Current|

* GlaxoSmithKline Pakistan
* GlaxoSmithKline Pharmaceuticals Ltd
* Stiefel Laboratories
* Tesaro
* ViiV Healthcare (85%)

|

Former|

Haleon

Predecessors,
acquisitions|

* Allen & Hanburys
* Beecham Group
* Block Drug
* Burroughs Wellcome
* Glaxo
* Glaxo Wellcome
* Human Genome Sciences
* Recherche et Industrie Thérapeutiques
* Reliant Pharmaceuticals
* S. E. Massengill Company
* SmithKline Beecham
* Smith, Kline & French

Products|

| Current|

| Pharma|

* Advair
* Alli
* Augmentin
* Avandia
* Beconase
* Boniva
* Flixonase
* Hycamtin
* Lamictal
* Paxil/Seroxat
* Serlipet
* Tagamet
* Ventolin
* Wellbutrin/Zyban
* Zantac … more

|

Vaccines|

* Arexvy
* Bexsero
* Boostrix
* Cervarix
* Engerix-B
* Fluarix
* FluLaval
* Havrix
* Hepatyrix
* Hiberix
* Infanrix
* H5N1 vaccine
* Kinrix
* Menveo
* Pandemrix
* Pediarix
* Rabavert
* Rotarix
* Shingrix
* Twinrix … more

Former|

* Actifed
* Advil
* Aquafresh
* BC Powder
* Biotene
* Caltrate
* Centrum
* ChapStick
* Emergen-C
* Eno
* Excedrin
* Flonase
* Geritol
* Goody's Powder
* Horlicks
* Lucozade
* Nicoderm
* Nicorette
* NiQuitin
* Parodontax
* Ribena
* Sensodyne
* Tums

People|

| Board of
Directors|

* Philip Hampton
* Emma Walmsley
* Simon Dingemans
* Roy M. Anderson
* Manvinder Banga
* Patrick Vallance
* Vivienne Cox
* Lynn Elsenhans
* Jesse Goodman
* Judy Lewent
* Urs Rohner
* Laurie Glimcher

|

Other|

* Thomas Beecham
* Silas M. Burroughs
* Mahlon Kline
* John K. Smith
* Henry Wellcome
* Andrew Witty
* Chris Gent

Litigation|

* Canada v. GlaxoSmithKline Inc.
* Christopher v. SmithKline Beecham Corp.
* GlaxoSmithKline Services Unlimited v Commission
* United States v. Glaxo Group Ltd.
* United States v. GlaxoSmithKline

Other|

* Drug Industry Documents Archive
* GlaxoSmithKline Prize
* Side Effects
* Study 329

* Category

Authority control databases |

* ISNI

|

*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template